Becker's Healthcare December 7, 2018
Anuja Vaidya

The FDA formally recognized Clinical Genome Resource consortium’s ClinGen Expert Curated Human Genetic Data, a public genomic database, as a source of valid scientific evidence.

Evidence from the database, which is funded by the National Institutes of Health, can now be used to support clinical validity in premarket FDA submissions. Test developers can use information from the database rather than having to generate information for themselves. Additionally, test developers will not have to demonstrate the reliability of the database to the agency.

In April, the FDA issued a final guidance that showcased the benefits of public databases for the accelerated development of genetic tests. The agency recognized the ClinGen database using the process detailed in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, FDA, Govt Agencies, Precision Medicine, Provider, Regulations, Technology
Related Articles:
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned
2023 Had Most Food Recalls Since Start Of COVID-19 Pandemic, Report Finds
Exo adds FDA-cleared AI tools to handheld ultrasound system
Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances

Share This Article